Paper20932003
p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells.
Eom HJ and 1 other. Environ Sci Technol, 2010. Cited by 231 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells. Papers, record 20932003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20932003
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- p38 MAPK activation, DNA damage, cell cycle arrest and apoptosis as mechanisms of toxicity of silver nanoparticles in Jurkat T cells.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Cycle | Major topic |
| Enzyme Activation | Major topic |
| Metal Nanoparticles | Major topic |
| Silver | Major topic |
| p38 Mitogen-Activated Protein Kinases | Major topic |
| Apoptosis | |
| DNA Damage | |
| Environmental Pollutants | |
| Humans | |
| Jurkat Cells | |
| Oxidative Stress |
Source PubMed
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42216990 | Antibacterial and osteogenic effect of EGCG/HAP/AgNPs composite coating on titanium surface. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/42216990 | PubMed |
| 42040035 | Examining The Effects of Silver Diamine Fluoride Treatment on the Surface Morphological Properties and Binding Strength of Demineralized Dentin to Glass Ionomer with and without Potassium Iodide and Glutathione : Examining The Effects of Silver Diamine Fluoride Treatment on the Surface Morphological Properties. | Galen Med J | 2024 | https://conductscience.org/library/papers/42040035 | PubMed |
| 41441470 | The Impact of the Reducing Agent on the Cytotoxicity and Selectivity Index of Silver Nanoparticles in Leukemia and Healthy Cells. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/41441470 | PubMed |
| 41347863 | Nanomaterial-mediated multidimensional regulation of the bone microenvironment: a precise therapeutic strategy for bone metabolic imbalance. | Drug Deliv | 2025 | https://conductscience.org/library/papers/41347863 | PubMed |
| 40999704 | Exploring the Potentials of Silver Nanoparticles in Overcoming Cisplatin Resistance in Lung Adenocarcinoma: Insights from Proteomic and Xenograft Mice Studies. | ACS Nano | 2025 | https://conductscience.org/library/papers/40999704 | PubMed |
| 40341630 | Facile phyto-mediated synthesis of ternary CuO/Mn3O4/ZnO nanocomposite using Nigella Sativa seeds extract: characterization,antimicrobial, and biomedical evaluations. | Sci Rep | 2025 | https://conductscience.org/library/papers/40341630 | PubMed |
| 39796246 | Nebulized Hybrid Nanoarchaeosomes: Anti-Inflammatory Activity, Anti-Microbial Activity and Cytotoxicity on A549 Cells. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/39796246 | PubMed |
| 39516320 | Biogenic silver nanoparticles incorporated hydrogel beads for anticancer and antibacterial activities. | Sci Rep | 2024 | https://conductscience.org/library/papers/39516320 | PubMed |
| 38726783 | Green Synthesis of Silver Nanoparticles and their Potential Applications in Mitigating Cancer. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/38726783 | PubMed |
| 38509420 | Harnessing nature's potential: Alpinia galanga methanolic extract mediated green synthesis of silver nanoparticle, characterization and evaluation of anti-neoplastic activity. | Bioprocess Biosyst Eng | 2024 | https://conductscience.org/library/papers/38509420 | PubMed |
| 37855967 | Long-term application of silver nanoparticles in dental restoration materials: potential toxic injury to the CNS. | J Mater Sci Mater Med | 2023 | https://conductscience.org/library/papers/37855967 | PubMed |
| 37854054 | A Review of Antibiotic Efficacy in COVID-19 Control. | J Immunol Res | 2023 | https://conductscience.org/library/papers/37854054 | PubMed |
| 37821481 | Synthesis of halloysite nanotubes decorated with green silver nanoparticles to investigate cytotoxicity, lipid peroxidation and induction of apoptosis in acute leukemia cells. | Sci Rep | 2023 | https://conductscience.org/library/papers/37821481 | PubMed |
| 37594589 | Biodistribution and intestinal inflammatory response following voluntary oral intake of silver nanoparticles by C57BL/6J mice. | Arch Toxicol | 2023 | https://conductscience.org/library/papers/37594589 | PubMed |
| 37566091 | Biogenic Silver Nanoparticles for Targeted Cancer Therapy and Enhancing Photodynamic Therapy. | Cells | 2023 | https://conductscience.org/library/papers/37566091 | PubMed |
| 37525184 | The effect of silver nanoparticles on learning and memory in rodents: "a systematic review". | J Occup Med Toxicol | 2023 | https://conductscience.org/library/papers/37525184 | PubMed |
| 37242455 | Morin Sensitizes MDA-MB-231 Triple-Negative Breast Cancer Cells to Doxorubicin Cytotoxicity by Suppressing FOXM1 and Attenuating EGFR/STAT3 Signaling Pathways. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37242455 | PubMed |
| 37034237 | mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles. | World J Hepatol | 2023 | https://conductscience.org/library/papers/37034237 | PubMed |
| 36823304 | Scaling-up strategies for controllable biosynthetic ZnO NPs using cell free-extract of endophytic Streptomyces albus: characterization, statistical optimization, and biomedical activities evaluation. | Sci Rep | 2023 | https://conductscience.org/library/papers/36823304 | PubMed |
| 36132767 | Role of inorganic nanoparticle degradation in cancer therapy. | Nanoscale Adv | 2020 | https://conductscience.org/library/papers/36132767 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MAPK14 | 1432 | PubTator's text mining | https://conductscience.org/library/genes/1432 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20932003
GET https://conductscience.org/api/papers/v1/20932003/cited_by?page=2